WO2007081777A3 - METHODS FOR ACCURATELY MEASURING FREE IgE IN THE PRESENCE OF AN ANTI-IgE THERAPEUTIC - Google Patents

METHODS FOR ACCURATELY MEASURING FREE IgE IN THE PRESENCE OF AN ANTI-IgE THERAPEUTIC Download PDF

Info

Publication number
WO2007081777A3
WO2007081777A3 PCT/US2007/000233 US2007000233W WO2007081777A3 WO 2007081777 A3 WO2007081777 A3 WO 2007081777A3 US 2007000233 W US2007000233 W US 2007000233W WO 2007081777 A3 WO2007081777 A3 WO 2007081777A3
Authority
WO
WIPO (PCT)
Prior art keywords
ige
accurately measuring
therapeutic
methods
measuring free
Prior art date
Application number
PCT/US2007/000233
Other languages
French (fr)
Other versions
WO2007081777A2 (en
Inventor
Mengyuan Patrick Liu
Original Assignee
Tanox Inc
Mengyuan Patrick Liu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc, Mengyuan Patrick Liu filed Critical Tanox Inc
Publication of WO2007081777A2 publication Critical patent/WO2007081777A2/en
Publication of WO2007081777A3 publication Critical patent/WO2007081777A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention provides methods and kits for accurately measuring the amount of IgE in a subject in the presence of an anti-IgE therapeutic, for use, for example in monitoring subjects undergoing treatment with anti-IgE therapeutics.
PCT/US2007/000233 2006-01-06 2007-01-05 METHODS FOR ACCURATELY MEASURING FREE IgE IN THE PRESENCE OF AN ANTI-IgE THERAPEUTIC WO2007081777A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75687406P 2006-01-06 2006-01-06
US60/756,874 2006-01-06

Publications (2)

Publication Number Publication Date
WO2007081777A2 WO2007081777A2 (en) 2007-07-19
WO2007081777A3 true WO2007081777A3 (en) 2007-10-18

Family

ID=38256910

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/000233 WO2007081777A2 (en) 2006-01-06 2007-01-05 METHODS FOR ACCURATELY MEASURING FREE IgE IN THE PRESENCE OF AN ANTI-IgE THERAPEUTIC

Country Status (1)

Country Link
WO (1) WO2007081777A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034714A1 (en) * 2009-07-24 2011-01-27 Biotez Berlin-Buch Gmbh Biochemisch-Technologisches Zentrum Immunoassay for the determination of the free target (antigen) in samples against which a therapeutic antibody is directed (Free Target Immunoassay)
CN103424545A (en) * 2013-08-12 2013-12-04 深圳市康博霖科技有限公司 Malachite green oxalate ELISA (enzyme-linked immunosorbent assay) detection kit and method
EP4045909A4 (en) * 2019-10-17 2024-02-21 Monash University Methods for detecting immune response

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849337A (en) * 1983-01-31 1989-07-18 Minnesota Mining And Manufacturing Company Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
US4968633A (en) * 1985-10-15 1990-11-06 Francesco Marcucci Mucosal allergo-test and relevant device for the determination of specific and total IgE
US6270746B1 (en) * 1999-02-17 2001-08-07 David H. Katz Assay for the identification of IgE antibody suppressors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849337A (en) * 1983-01-31 1989-07-18 Minnesota Mining And Manufacturing Company Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
US4968633A (en) * 1985-10-15 1990-11-06 Francesco Marcucci Mucosal allergo-test and relevant device for the determination of specific and total IgE
US6270746B1 (en) * 1999-02-17 2001-08-07 David H. Katz Assay for the identification of IgE antibody suppressors

Also Published As

Publication number Publication date
WO2007081777A2 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
WO2009079587A3 (en) Biomarkers for sensitivity to anti-igf1r therapy
CA2726071A1 (en) Blood glucose monitoring device
WO2009158035A3 (en) Methods for dosing an activin-actriia antagonist and monitoring of treated patients
EP2117422A4 (en) A method and system for determining a cerebrovascular autoregulation state of a patient
WO2013063155A3 (en) Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
WO2012054638A3 (en) Nmr systems and methods for the detection of analytes
WO2008063413A3 (en) Gene expression profiling for identification, monitoring, and treatment of lung cancer
WO2010065557A3 (en) Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis
WO2007061755A3 (en) Systems and methods to assess one or more body fluid metrics
EP4234583A3 (en) Evaluation and treatment of bradykinin-mediated disorders
WO2009092386A8 (en) A new method to measure and characterize microvesicles in the human body fluids
WO2008055078A3 (en) Identification of emotional states using physiological responses
EP1942801A4 (en) Analyte monitoring device and methods of use
WO2007115305A3 (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor
WO2011008581A3 (en) Devices, methods, and kits for determining analyte concentrations
WO2008143639A3 (en) Gene expression profiling for identification, monitoring, and treatment of cervical cancer
WO2012160527A3 (en) Integrity evaluation system in an implantable hearing prosthesis
WO2008152656A3 (en) Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma
WO2010080702A3 (en) Gene expression profiling for the identification, monitoring, and treatment of prostate cancer
WO2008131361A3 (en) Biosensors for measuring analytes in the interstitial fluid
WO2008014135A3 (en) Non-invasive analyte measurement glasses and method of use
WO2012067970A3 (en) Transcriptional repression leading to parkinson's disease
CA2815892C (en) Analytical methods and arrays for use in the same
WO2008058014A3 (en) Method and apparatus for noninvasive probe/skin tissue contact sensing

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07716338

Country of ref document: EP

Kind code of ref document: A2